KD-295

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameKD-295

Drug Alias NameFlu pandemic - GlaxoSmithKlineCell culture based H5N1 vaccine - GlaxoSmithKlineEmulsion Cell Culture Influenza HA Vaccine (Prototype)influenza HA vaccineinfluenza HA vaccine KMB +[6]

ClassificationVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsInfluenza, Human

Approved Indications in ChinaN/A

Original Approved Country/TerritoryJapan

Original Approved Date2014/01/01

Country/TerritoryBelgiumUnited StatesAustria +[4]

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc Valneva

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIntercell Usa Inc

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeJ07BB